Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Titel:
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Auteur:
Chappell, Keith J Mordant, Francesca L Li, Zheyi Wijesundara, Danushka K Ellenberg, Paula Lackenby, Julia A Cheung, Stacey T M Modhiran, Naphak Avumegah, Michael S Henderson, Christina L Hoger, Kym Griffin, Paul Bennet, Jillian Hensen, Luca Zhang, Wuji Nguyen, Thi H O Marrero-Hernandez, Sara Selva, Kevin J Chung, Amy W Tran, Mai H Tapley, Peter Barnes, James Reading, Patrick C Nicholson, Suellen Corby, Stavroula Holgate, Thomas Wines, Bruce D Hogarth, P Mark Kedzierska, Katherine Purcell, Damian F J Ranasinghe, Charani Subbarao, Kanta Watterson, Daniel Young, Paul R Munro, Trent P